Monitoring pediatric antidepressant use

Area of Science:

• Pediatric pharmacology
• Health services research
• Clinical informatics

Background:

• Monitoring pediatric antidepressant use is crucial for patient safety.
• Existing methods may not adequately address FDA recommendations or resource limitations.
• Improved communication between providers and patients is needed.

Purpose of the Study:

• To evaluate the PhaST (Provider-patient communication and safety tracking) system for monitoring pediatric antidepressant use.
• To assess the feasibility and effectiveness of the PhaST system in a clinical trial setting.
• To determine if PhaST can improve patient safety, quality of care, and treatment adherence.

Main Methods:

• The PhaST system utilizes interactive voice response (IVR) technology for patient monitoring.
• Calls are managed by physician extenders, with reports sent to physicians.
• The system incorporates FDA recommendations and considers system and family resources.

Main Results:

• Pilot and preliminary data indicate successful participant reachability via telephone.
• Monitoring calls were completed effectively over time.
• Physician extenders successfully responded to positive calls, assessing concern levels and action steps.

Conclusions:

• The PhaST system demonstrates sensitivity in monitoring outpatients for antidepressant adverse effects.
• Its use of inexpensive IVR technology and physician extenders may enhance provider-patient communication.
• PhaST shows promise for improving patient safety, quality of care, medication adherence, and behavior management.